Literature DB >> 20425425

Is Hodgkin lymphoma just another B-cell lymphoma?

Harald Stein1, Roshanak Bob.   

Abstract

Hodgkin disease was the first defined lymphoid neoplasm. For many decades it was regarded as a disease separate from non-Hodgkin lymphoma. However, recent studies have shown that the dysplastic cells of Hodgkin lymphoma (HL) are monoclonal B cells. This finding raised again the question "Is HL just another B-cell lymphoma?" This article reviews the different aspects of HL and B-cell non-Hodgkin lymphoma (B-NHL), concluding that-despite the same cell of origin-fundamental differences exist in morphology, cellular composition, immunophenotype, activation or inhibition of transcription factors, epigenetics, and clinical behavior. These findings lead us to conclude that HL and B-NHLs should stay as two separate categories.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20425425     DOI: 10.1007/s11899-009-0018-1

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   3.952


  34 in total

1.  Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression.

Authors:  Alexey Ushmorov; Olga Ritz; Michael Hummel; Frank Leithäuser; Peter Möller; Harald Stein; Thomas Wirth
Journal:  Blood       Date:  2004-07-29       Impact factor: 22.113

2.  Heterogeneity of BCL6 rearrangements in nodular lymphocyte predominant Hodgkin's lymphoma.

Authors:  Iwona Wlodarska; Michel Stul; Chris De Wolf-Peeters; Anne Hagemeijer
Journal:  Haematologica       Date:  2004-08       Impact factor: 9.941

3.  Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.

Authors:  Christoph Renné; José Ignacio Martín-Subero; Martin-Leo Hansmann; Reiner Siebert
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  Epstein-Barr virus and bcl-2 protein overexpression are not detected in the neoplastic cells of nodular lymphocyte predominance Hodgkin's disease.

Authors:  S Alkan; C W Ross; C A Hanson; B Schnitzer
Journal:  Mod Pathol       Date:  1995-06       Impact factor: 7.842

5.  Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription.

Authors:  H Stein; T Marafioti; H D Foss; H Laumen; M Hummel; I Anagnostopoulos; T Wirth; G Demel; B Falini
Journal:  Blood       Date:  2001-01-15       Impact factor: 22.113

6.  Nodular lymphocyte predominance Hodgkin's disease. A distinct clinicopathological entity.

Authors:  D Y Mason; P M Banks; J Chan; M L Cleary; G Delsol; C de Wolf Peeters; B Falini; K Gatter; T M Grogan; N L Harris
Journal:  Am J Surg Pathol       Date:  1994-05       Impact factor: 6.394

7.  Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease.

Authors:  Teresa Marafioti; Michela Pozzobon; Martin-Leo Hansmann; Georges Delsol; Stefano A Pileri; David Y Mason
Journal:  Blood       Date:  2003-07-24       Impact factor: 22.113

8.  PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:  Syong H Nam-Cha; Giovanna Roncador; Lydia Sanchez-Verde; Santiago Montes-Moreno; Agustín Acevedo; Purificación Domínguez-Franjo; Miguel A Piris
Journal:  Am J Surg Pathol       Date:  2008-08       Impact factor: 6.394

9.  Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

Authors:  Ines Schwering; Andreas Bräuninger; Ulf Klein; Berit Jungnickel; Marianne Tinguely; Volker Diehl; Martin-Leo Hansmann; Riccardo Dalla-Favera; Klaus Rajewsky; Ralf Küppers
Journal:  Blood       Date:  2002-09-26       Impact factor: 22.113

10.  Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.

Authors:  Verena Brune; Enrico Tiacci; Ines Pfeil; Claudia Döring; Susan Eckerle; Carel J M van Noesel; Wolfram Klapper; Brunangelo Falini; Anja von Heydebreck; Dirk Metzler; Andreas Bräuninger; Martin-Leo Hansmann; Ralf Küppers
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

View more
  2 in total

1.  Hemophagocytic Syndrome Associated with Hodgkin's Lymphoma First Presenting as Fever and Pancytopenia.

Authors:  Ramon Andrade Bezerra de Mello; Elsa Fonseca; Manuela Brochado; João Manuel Quinaz
Journal:  Case Rep Med       Date:  2010-11-07

2.  An IL12-IL2-antibody fusion protein targeting Hodgkin's lymphoma cells potentiates activation of NK and T cells for an anti-tumor attack.

Authors:  Tobias Jahn; Martin Zuther; Björn Friedrichs; Claudia Heuser; Stefan Guhlke; Hinrich Abken; Andreas A Hombach
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.